AI-assisted Detection of Missed Colonic Polyps
Artificial Intelligence-Assisted Real-time Detection of Missed Lesions During Colonoscopy: A Prospective Study
1 other identifier
interventional
52
1 country
1
Brief Summary
A prospective validation of real time deep learning artificial intelligence model for detection of missed colonic polyps
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 10, 2020
CompletedFirst Posted
Study publicly available on registry
January 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedMarch 4, 2020
March 1, 2020
1 month
January 10, 2020
March 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adenoma miss rate
The number of patient had at least one missed adenoma
During the colonoscopy procedure
Secondary Outcomes (3)
Total number of adenoma missed
During the colonoscopy procedure
Colonic polyp miss rate
During the colonoscopy procedure
Total number of missed polyps
During the colonoscopy procedure
Study Arms (1)
Artificial intelligence-Assisted real time colonoscopy
EXPERIMENTALAI assisted real-time detection of colonic lesions
Interventions
The colonoscopy was performed under artificial intelligence assistance
Eligibility Criteria
You may qualify if:
- consecutive adult patients, age 40 or above, who were scheduled to have outpatient colonoscopy in the Queen Mary Hospital were invited to participate
You may not qualify if:
- Patients were excluded if they were unable to provide informed consent, considered to be unsafe for taking biopsy or polypectomy including patients with bleeding tendency and those with severe comorbid illnesses.
- Also, patients with history of inflammatory bowel disease, familial adenomatous polyposis, Peutz-Jeghers syndrome or other polyposis syndromes were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen Mary Hospital
Hong Kong, Hong Kong
Related Publications (1)
Lui TKL, Hui CKY, Tsui VWM, Cheung KS, Ko MKL, Foo DCC, Mak LY, Yeung CK, Lui TH, Wong SY, Leung WK. New insights on missed colonic lesions during colonoscopy through artificial intelligence-assisted real-time detection (with video). Gastrointest Endosc. 2021 Jan;93(1):193-200.e1. doi: 10.1016/j.gie.2020.04.066. Epub 2020 May 4.
PMID: 32376335DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ka Luen, Thomas Lui
Queen Mary Hospital, the University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
January 10, 2020
First Posted
January 14, 2020
Study Start
January 1, 2020
Primary Completion
February 1, 2020
Study Completion
March 1, 2020
Last Updated
March 4, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share